More intelligence articles

Rare Diseases Day

More than other conditions, rare diseases require a human touch, but technology can provide a vital helping hand

Visualising medicine

How creative can simplify the complex

Combining therapies and combining research

The strategy for retaining antibiotic security

The importance of co-creation with patients

Overcoming the barriers

Three billboards on the road to multichannel

Chris Ross examines the trends driving multichannel communication in 2019

Cell and gene therapy

Tackling the manufacturing cost and complexity challenges

2019: CRISPR and therapeutic gene editing comes of age

Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?

Cutting through the noise: CRISPR

AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery

Immuno-oncology in 2019: the rapid evolution continues

Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?

Immunotherapy combination trials Q&A

By Chris Learn and Martin Lachs

Whenever, wherever – the new face of flexible working

Flexible, agile, dynamic or smart working is now one of the key differentiators for agency employers

Drug launches to watch in 2019

13 market-changing drugs expected to hit the European market this year

Why precision medicine demands precision engagement

The speed of innovation brings its own challenges, says cloud computing expert

Unlocking the potential of science and technology in the UK

Greater collaboration is vital in post-Brexit UK, says Alderley Park leader

NHS regional footprints

What to expect from 2019